PMID: 22237259

Liu G, Cheng D, Ding K, Le Maitre A, Liu N, Patel D, Chen Z, Seymour L, Shepherd FA, Tsao MS
Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer.
J Thorac Oncol. 2012 Feb;7(2):316-22., [PubMed]
Sentences
No. Mutations Sentence Comment
35 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 22237259:35:51
status: NEW
view ABCG2 p.Val12Met details
 We excluded the analysis of the ABCG2 34GϾA (V12M, rs2231137) polymorphism17 because it had a 2% minor allele frequency in our Caucasian-predominant population. Login to comment